Multinational drug firms bite bigger share

Published: 2012-08-22 07:00:00

Updated: 2012-08-22 07:00:00

With foreign drug makers taking a bigger share of the domestic prescription market taking a bigger share of the domestic prescription market, Korea's pharmaceutical companies have seen falling market share.

Korean companies are feeling pressure from all sides. While relying too much on selling...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK